Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
NCT06291922
Summary
The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.
Eligibility
Inclusion Criteria: 1. ≥ 18 years of age 2. Newly implanted with a HeartMate 3™ LVAD for the first time 3. Able to ambulate independently (with or without the use of an assistive device) 4. Owns a smartphone with Internet connection 5. Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge Exclusion Criteria: 1\. Major comorbidities or limitations that may interfere with exercise training (including significant orthopedic/neurologic limitations, decompensated heart failure, uncontrolled arrhythmias, unstable angina)
Conditions2
Locations4 sites
Michigan
1 siteOhio
1 sitePennsylvania
1 siteUtah
1 siteBrowse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06291922